Skip to main
AMN

AMN Stock Forecast & Price Target

AMN Analyst Ratings

Based on 6 analyst ratings
Hold
Strong Buy 17%
Buy 33%
Hold 33%
Sell 17%
Strong Sell 0%

Bulls say

AMN Healthcare Services is poised for long-term growth as its nurse and allied staffing business returns to a growth trend, supported by stable bill rates and improved performance. The company has a strong financial position with a decreasing net leverage and a diversified revenue stream, with about 70% of revenue coming from its traditional nurse and allied staffing segment. Despite the challenges posed by COVID and increased competition, AMN has shown resilience and adaptability, making strategic acquisitions in the technology and workforce solutions space and optimizing its tiered service model to mitigate pricing pressures in its language services segment.

Bears say

AMN Healthcare Services is facing significant challenges in all of its business segments, including declining revenue and gross margins in its Physician and Leadership and Technology and Workforce units, as well as a lack of growth potential in the VMS software market. The company also has a high level of debt and is projecting only moderate revenue and EBITDA growth in the coming years. Despite the potential for a rebound in the back half of 2027, the company's historical valuation and current margin compression both signal a negative outlook for its stock performance in the near future.

AMN has been analyzed by 6 analysts, with a consensus rating of Hold. 17% of analysts recommend a Strong Buy, 33% recommend Buy, 33% suggest Holding, 17% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of AMN Healthcare Services and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About AMN Healthcare Services (AMN) Forecast

Analysts have given AMN a Hold based on their latest research and market trends.

According to 6 analysts, AMN has a Hold consensus rating as of Aug 13, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $30.17, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $30.17, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

AMN Healthcare Services (AMN)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.